+61 2 9905 0133
7/27 Dale Street Brookvale 2100 SYDNEY NSW, AUSTRALIA
Cellabs is a Sydney based "boutique" diagnostics company, specialising in the design, development, and manufacture of immunodiagnostic kits for tropical and infectious diseases. Established in 1985 by immunologist Dr A. M. Smithyman, Cellabs is Australia's oldest private biotechnology company.
By 1990, Cellabs had released its first range of commercial diagnostic tests for giardia, cryptosporidium, and chlamydia; all of which found ready markets both locally and internationally. The company has steadily expanded its range of products and now markets over 20 diagnostic kits worldwide.
The company has a particular interest in the Neglected Tropical Diseases such as malaria, leishmaniasis, elephantiasis and schistosomiasis; diseases that impose a massive burden on the global population. Malaria, for example, kills one child every 30 seconds, is endemic in 87 countries with and estimated 219 million cases and 435,000 deaths worldwide (World Malaria Report 2018).
In 1998, Cellabs formed a strong relationship with its sister company, TropBio Pty Ltd, a company producing a range of human and veterinary diagnostics products complementary to the Cellabs range, including the WHO recommended Og4C3 Filariasis Ag ELISA. By 2013, Tropbio moved to the Cellabs premises in Sydney, Australia.
CELLABS KEY EXECUTIVES
Dr Anthony Smithyman, Managing Director
Dr Diane Dogcio Hall, Quality & Operations Manager
Dr G-H Rajasekariah, Chief Scientist, Research & Development